Prednisolone prevents decreases in trabecular bone mass and strength by reducing bone resorption and bone formation defect in adjuvant-induced arthritic rats

Bone

Volumn 23, Issue 4, 1998, Pages 353-360

  Okazaki, Y ^a   Tsurukami, H ^a   Nishida, S ^a   Okimoto, N ^a   Aota, S ^b   Takeda, S ^c   Nakamura, T ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^c CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Bone formation rate; Bone mineral; Carboxyterminal pyridinoline cross linked telopeptide of type 1 collagen; Compressive load; Osteocalcin; Osteoclast

Indexed keywords

COLLAGEN TYPE 1; OSTEOCALCIN; PREDNISOLONE;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE ATROPHY; BONE MASS; BONE MINERAL; BONE STRENGTH; FEMALE; INTRAMUSCULAR DRUG ADMINISTRATION; NONHUMAN; OSSIFICATION; OSTEOCLAST; OSTEOLYSIS; RAT;

ANIMALS; ARTHRITIS, EXPERIMENTAL; BONE DENSITY; BONE DISEASES, METABOLIC; BONE RESORPTION; COLLAGEN; COLLAGEN TYPE I; EDEMA; FEMALE; FREUND'S ADJUVANT; GLUCOCORTICOIDS; HINDLIMB; LUMBAR VERTEBRAE; OSTEOCALCIN; OSTEOCLASTS; PEPTIDES; PREDNISOLONE; RATS; RATS, SPRAGUE-DAWLEY; WEIGHT-BEARING;

EID: 0032189137     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(98)00116-1     Document Type: Article

References (39)

1. Adinoff A.D., Hollister J.R. Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med. 309:1983;265-268.
2. Aota S., Nakamura T., Suzuki K., Tanaka Y., Okazaki Y., Segawa Y., Miura M., Kikuchi S. Effects of indomethacin administration on bone turnover and bone mass in adjuvant-induced arthritis in rats. Calcif Tissue Int. 59:1996;385-391.
3. Bonnet J., Zerath E., Picaud N., Lesur C., Mattio A., Tordjman C., Hott M., Marie P.J. Bone morphometric changes in adjuvant-induced polyarthritic osteopenia in rats Evidence for an early bone formation defect . J Bone Miner Res. 8:1993;659-668.
4. Bressot C., Menunier P.J., Chapuy M.C., Lejeune E., Edouard C., Darby A.J. Histomorphometric profile, pathophysiology and reversibility of corticosteroid-induced osteoporosis. Metab Bone Dis Rel Res. 1:1979;303-311.
5. Dempster D.W. Bone histomorphometry in glucocorticoid-induced osteoporosis. J Bone Miner Res. 4:1989;137-141.
6. Dempster D.W. Exploiting and bypassing the bone remodeling cycle to optimize the treatment of osteoporosis. J Bone Miner Res. 12:1997;1152-1154.
7. Ferretti J.L., Vazquez S.O., Delgado C.J., Capozza R., Cointry G. Biphasic dose-response curves of cortisol effects on rat diaphyseal bone biomechanics. Calcif Tissue Int. 50:1992;49-54.
8. Godschalk M.F., Downs R.W. Effect of short-term glucocorticoids on serum osteocalcin in healthy young men. J Bone Miner Res. 3:1988;113-115.
9. Goulding A., Gold E. Effects of chronic prednisolone treatment on bone resorption and bone composition in intact and ovariectomized rats and in ovariectomized rats receiving beta-estradiol. Endocrinology. 122:1988;482-487.
10. Hall G.M., Spector T.D., Griffin A.J., Jawad A.S., Hall M.L., Doyle D.V. The effect of rheumatoid arthritis and steroid therapy on bone density in postmenopausal women. Arthritis Rheum. 36:1993;1510-1516.
11. Katsumata T., Nakamura T., Ohnishi H., Sakurama T. Intermittent cyclical etidronate treatment maintains the mass, structure and the mechanical property of bone in ovariectomized rats. J Bone Miner Res. 10:1995;921-931.
12. King C.S., Weir E.C., Gundberg C.W., Fox J., Insogna K.L. Effects of continuous glucocorticoid infusion on bone metabolism in the rat. Calcif Tissue Int. 59:1996;184-191.
13. Kukreja S.C., Bowser E.N., Hargis G.K., Henderson W.J., Williams G.A. Mechanisms of glucocorticoid-induced osteopenia Role of parathyroid glands . Proc Soc Exp Biol Med. 152:1976;358-361.
14. Laan R.F., van Riel P.L., van de Putte L.B., van Erning L.J., van't Hof M.A., Lemmens J.A. Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis A randomized, controlled study . Ann Intern Med. 119:1993;963-968.
15. Lems W.F., Gerrits M.I., Jacobs J.W., van Vugt R.M., van Rijn H.J., Bijlsma J.W. Changes in (markers of) bone metabolism during high dose corticosteroid pulse treatment in patients with rheumatoid arthritis. Ann Rheum Dis. 55:1996;288-293.
16. Li M., Shen Y., Halloran B.P., Baumann B.D., Miller K., Wronski T.J. Skeletal response to corticosteroid deficiency and excess in growing male rats. Bone. 19:1996;81-88.
17. Lindgren J.U., Johnell O., DeLuca H.F. Studies of bone tissue in rats treated by prednisolone and 1,25-(OH)2D3. Clin Orthop. 181:1983;264-268.
18. LoCascio V., Bonucci E., Imbimbo B., Ballanti P., Adami S., Milani S., Tartarotti D., DellaRocca C. Bone loss in response to long-term glucocorticoid therapy. Bone Miner. 8:1990;39-51.
19. Lukert B.P., Raisz L.G. Glucocorticoid-induced osteoporosis Pathogenesis and management . Ann Intern Med. 112:1990;352-364.
20. McCulloch C.A., Tenenbaum H.C. Dexamethasone induces proliferation and terminal differentiation of osteogenic cells in tissue culture. Anat Rec. 215:1986;397-402.
21. Mosekilde L., Danielsen C.C., Knudsen U.B. The effect of aging and ovariectomy on the vertebral bone mass and biomechanical properties of mature rats. Bone. 14:1993;1-6.
22. Motoie H., Nakamura T., O'Uchi N., Nishikawa H., Kanoh H., Abe T., Kawashima H. Effects of the bisphosphonate YM175 on bone mineral density, strength, structure, and turnover in ovariectomized beagles on concomitant dietary calcium restriction. J Bone Miner Res. 10:1995;910-920.
23. Murakami H., Nakamura T., Tsurukami H., Abe M., Barbier A., Suzuki K. Effects of tiludronate on bone mass, structure, and turnover at the epiphyseal, primary, and secondary spongiosa in the proximal tibia of growing rats after sciatic neurectomy. J Bone Miner Res. 9:1994;1355-1364.
24. Ohnishi H., Nakamura T., Narusawa K., Murakami H., Abe M., Barbier A., Suzuki K. Bisphosphonate tiludronate increases bone strength by improving mass and structure in established osteopenia after ovariectomy in rats. Bone. 21:1997;335-343.
25. Ørtoft G., Bruel A., Andreassen T.T., Oxlund H. Growth hormone is not able to counteract osteopenia of rat cortical bone induced by glucocorticoid with protracted effect. Bone. 17:1995;543-548.
26. Ørtoft G., Oxlund H. Reduced strength of rat cortical bone after glucocorticoid treatment. Calcif Tissue Int. 43:1988;376-382.
27. Parfitt A.M., Drezner M.K., Glorieux F.H., Kanis J.A., Malluche H., Meunier P.J., Ott S.M., Recker R.R. Bone histomorphometry: Standardization of nomenclature, symbols, and units Report of the ASBMR Histomorphometry Nomenclature Committee . J Bone Miner Res. 2:1987;595-610.
28. Pearson C.M., Wood F.D. Studies of other lesions induced in rats by the injection of microbacterial adjuvant VII. Pathologic details of the arthritis and spondylitis . Am J Pathol. 42:1963;73-95.
29. Reid D.M., Kennedy N.S., Smith M.A., Nicoll J., Brown N., Tothill P., Nuki G. Bone loss in rheumatoid arthritis and primary generalized osteoarthrosis Effects of corticosteroids, suppressive antirheumatic drugs and calcium supplements . Br J Rheumatol. 25:1986;253-259.
30. Sakakura M., Takebe K., Nakagawa S. Inhibition of luteinizing hormone secretion induced by synthetic LRH by long-term treatment with glucocorticoids in human subjects. J Clin Endocrinol Metab. 40:1975;774-779.
31. Sambrook P.N., Cohen M.L., Eisman J.A., Pocock N.A., Champion G.D., Yeates M.G. Effects of low dose corticosteroids on bone mass in rheumatoid arthritis A longitudinal study . Ann Rheum Dis. 48:1989;535-538.
32. Sambrook P.N., Eisman J.A., Champion G.D., Pocock N.A. Sex hormone status and osteoporosis in postmenopausal women with rheumatoid arthritis. Arthritis Rheum. 31:1988;973-978.
33. Segawa Y., Nakamura T., Aota S., Tanaka Y., Yoshida K., Tsuzuike N., Matsuda K. Changes in urinary deoxypyridinoline level and vertebral bone mass in the development of adjuvant-induced arthritis in rats. Bone. 17:1995;57-62.
34. Segawa Y., Yamaura M., Aota S., Omata T., Tuzuike N., Itokazu Y., Oka H., Tamaki H., Nakamura T. Methotrexate maintains bone mass by preventing both a decrease in bone formation and an increase in bone resorption in adjuvant-induced arthritic rats. Bone. 20:1997;457-464.
35. Tanaka Y., Nakamura T., Nishida S., Suzuki K., Takeda S., Sato K., Nishii Y. Effects of a synthetic vitamin D analog, ED-71, on bone dynamics and strength in cancellous and cortical bone in prednisolone-treated rats. J Bone Miner Res. 11:1996;325-336.
36. Uchiyama Y., Takamori H., Miyama K., Takano E., Nakajima H., Sato T., Nakamura T. Modulation of bone mass, strength and turnover by a new benzamide compound, DU-6712, in adjuvant-induced arthritic rats. Calcif Tissue Int. 62:1998;519-526.
37. Weichman B.M., Chau T.T., Rona G. Histopathologic evaluation of the effects of etodolac in established adjuvant arthritis in rats Evidence for reversal of joint damage . Arthritis Rheum. 30:1987;466-470.
38. Wong M.M., Rao L.G., Ly H., Hamilton L., Tong J., Sturtridge W., McBroom R., Aubin J.E., Murray T.M. Long-term effects of physiologic concentrations of dexamethasone on human bone-derived cells. J Bone Miner Res. 5:1990;803-813.
39. Yasumura S. Effect of adrenal steroids on bone resorption in rats. Am J Physiol. 230:1976;90-93.